Correlation Between Bank Central and Lexaria Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank Central and Lexaria Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Central and Lexaria Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Central Asia and Lexaria Bioscience Corp, you can compare the effects of market volatilities on Bank Central and Lexaria Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Central with a short position of Lexaria Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Central and Lexaria Bioscience.

Diversification Opportunities for Bank Central and Lexaria Bioscience

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bank and Lexaria is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Bank Central Asia and Lexaria Bioscience Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexaria Bioscience Corp and Bank Central is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Central Asia are associated (or correlated) with Lexaria Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexaria Bioscience Corp has no effect on the direction of Bank Central i.e., Bank Central and Lexaria Bioscience go up and down completely randomly.

Pair Corralation between Bank Central and Lexaria Bioscience

Assuming the 90 days horizon Bank Central Asia is expected to generate 0.33 times more return on investment than Lexaria Bioscience. However, Bank Central Asia is 3.05 times less risky than Lexaria Bioscience. It trades about -0.22 of its potential returns per unit of risk. Lexaria Bioscience Corp is currently generating about -0.29 per unit of risk. If you would invest  1,510  in Bank Central Asia on November 4, 2024 and sell it today you would lose (80.00) from holding Bank Central Asia or give up 5.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bank Central Asia  vs.  Lexaria Bioscience Corp

 Performance 
       Timeline  
Bank Central Asia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bank Central Asia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Lexaria Bioscience Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lexaria Bioscience Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Bank Central and Lexaria Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank Central and Lexaria Bioscience

The main advantage of trading using opposite Bank Central and Lexaria Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Central position performs unexpectedly, Lexaria Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexaria Bioscience will offset losses from the drop in Lexaria Bioscience's long position.
The idea behind Bank Central Asia and Lexaria Bioscience Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Money Managers
Screen money managers from public funds and ETFs managed around the world